havent got a problem with any of the above SS. a snippet from an email from Victoria below for interest........
"we already have the funds in QBiotics for development of EBC-46 to full registration for the AU/NZ veterinary market and revenue from sales of the vet drug will cover registration of the vet drug for USA and Europe (also note that we expect initial modest revenue from the vet drug this year under a Minor Use Permit and then a big marketing push next year after full registration of the vet drug)" ................ i have no idea of what the cost will be for full registration for the USA and Europe market will be but she seems as though they have it covered with potential revenue cheers PC
